Oral disease in relation to future risk of dementia and cognitive decline: Prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial

Examine the association of oral disease with future dementia/cognitive decline in a cohort of people with type 2 diabetes. A total of 11,140 men and women aged 55–88 years at study induction with type 2 diabetes participated in a baseline medical examination when they reported the number of natural...

Full description

Saved in:

Bibliographic Details
Published in:	European psychiatry Vol. 28; no. 1; pp. 49 - 52
Main Authors:	Batty, G.-D., Li, Q., Huxley, R., Zoungas, S., Taylor, B.-A., Neal, B., de Galan, B., Woodward, M., Harrap, S.-B., Colagiuri, S., Patel, A., Chalmers, J.
Format:	Journal Article
Language:	English
Published:	Paris Elsevier SAS 01.01.2013 Elsevier
Subjects:	Age Factors Aged Aged, 80 and over Biological and medical sciences Cognition Cognition Disorders - etiology Cognitive decline Cohort study Dementia Dementia - etiology Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Female Humans Internal Medicine Male Medical sciences Middle Aged Neuropsychological Tests Oral disease Periodontal Diseases - complications Prospective Studies Psychiatry Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Quality of Life Risk Sex Factors Socioeconomic Factors Cognitive decline Oral disease Cohort study Dementia Endocrinopathy Evaluation Cognitive disorder Diabetes mellitus Cardiovascular disease Intellectual deterioration Vascular disease Follow up study Risk factor Degenerative disease Oral cavity disease Release
ISSN:	0924-9338, 1778-3585, 1778-3585
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!